Headache epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:


===Gender===
===Gender===
*[Disease name] affects men and women equally.
*women are more commonly affected by migraine than men.  
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
*Men are more commonly affected by cluster than women. The male to female ratio is approximately 2.5 to 1.<ref name="pmid29720812">{{cite journal| author=Wei DY, Yuan Ong JJ, Goadsby PJ| title=Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis. | journal=Ann Indian Acad Neurol | year= 2018 | volume= 21 | issue= Suppl 1 | pages= S3-S8 | pmid=29720812 | doi=10.4103/aian.AIAN_349_17 | pmc=5909131 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29720812  }} </ref>


===Region===
===Region===

Revision as of 04:11, 8 April 2021

Headache Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Headache from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Headache epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Headache epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Headache epidemiology and demographics

CDC on Headache epidemiology and demographics

Headache epidemiology and demographics in the news

Blogs on Headache epidemiology and demographics

Directions to Hospitals Treating Headache

Risk calculators and risk factors for Headache epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.*Worldwide Prevalence of patient with secondary headache is approximately 18%. The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.

Epidemiology and Demographics

Prevalence

  • The prevalence of cluster headache is approximately 3 to 150 per 100,000 individuals worldwide.[1]
  • Worldwide Prevalence of patient with secondary headache is approximately 18%.[2]
  • The prevalence of Migraine headache is estimated to be 12 to 15 percent of general population.[3]

Age

  • Patients of all age groups may develop headache.
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • Cluster headache usually affects women of the Aferican -American and Caucasians.[4]

Gender

  • women are more commonly affected by migraine than men.
  • Men are more commonly affected by cluster than women. The male to female ratio is approximately 2.5 to 1.[1]

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

}

References

  1. 1.0 1.1 Wei DY, Yuan Ong JJ, Goadsby PJ (2018). "Cluster Headache: Epidemiology, Pathophysiology, Clinical Features, and Diagnosis". Ann Indian Acad Neurol. 21 (Suppl 1): S3–S8. doi:10.4103/aian.AIAN_349_17. PMC 5909131. PMID 29720812.
  2. Do TP, Remmers A, Schytz HW, Schankin C, Nelson SE, Obermann M; et al. (2019). "Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list". Neurology. 92 (3): 134–144. doi:10.1212/WNL.0000000000006697. PMC 6340385. PMID 30587518.
  3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001). "Prevalence and burden of migraine in the United States: data from the American Migraine Study II". Headache. 41 (7): 646–57. doi:10.1046/j.1526-4610.2001.041007646.x. PMID 11554952.
  4. Reed C, Gordon S (1966). "Anaemia and polycythaemia in haemorrhagic telangiectasia". Med J Aust. 1 (11): 449–51. doi:10.5694/j.1326-5377.1966.tb72472.x. PMID 5909131.

Template:WikiDoc Sources